Equitable Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Sell |
49,730
-1,687
| -3% | -$116K | 0.03% | 421 |
|
|
2025
Q1 | $3.57M | Buy |
51,417
+141
| +0.3% | +$9.79K | 0.03% | 369 |
|
|
2024
Q4 | $4.41M | Sell |
51,276
-24,843
| -33% | -$2.14M | 0.04% | 309 |
|
|
2024
Q3 | $9.06M | Buy |
76,119
+13,117
| +21% | +$1.56M | 0.09% | 188 |
|
|
2024
Q2 | $8.99M | Buy |
63,002
+7,973
| +14% | +$1.14M | 0.09% | 173 |
|
|
2024
Q1 | $7.07M | Buy |
55,029
+25,057
| +84% | +$3.22M | 0.08% | 187 |
|
|
2023
Q4 | $3.1M | Buy |
29,972
+17,681
| +144% | +$1.83M | 0.04% | 304 |
|
|
2023
Q3 | $1.12M | Buy |
12,291
+2,271
| +23% | +$207K | 0.02% | 515 |
|
|
2023
Q2 | $811K | Buy |
10,020
+6,326
| +171% | +$512K | 0.01% | 576 |
|
|
2023
Q1 | $294K | Buy |
+3,694
| New | +$294K | ﹤0.01% | 804 |
|